DM
CSCI

Deerfield Management’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Deerfield Management’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-90
Closed -$482K – 136
2015
Q1 		$482K Buy
+90
New +$516K 0.02% 116

Other funds holding CSCI

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Azzad Asset Management Falls Church, Virginia $1.13B AUM 38.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Deerfield Management's CSCI Position: Q2 2015 in Review

Deerfield Management sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q2 2015, closing a stake of 90 shares — an estimated $482K sold.

Deerfield Management first reported a position in CSCI in Q1 2015 and held it in 1 quarter. The position peaked at $482K in Q1 2015. 10 funds tracked by Wall St. Rank hold CSCI as of Q2 2015.

  • Deerfield Management reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Deerfield Management sold 90 COSCIENS Biopharma Inc. Common Stock shares in Q2 2015, an estimated $482K.
  • Deerfield Management first reported a position in COSCIENS Biopharma Inc. Common Stock in Q1 2015 and held it in 1 quarter.
  • Deerfield Management's COSCIENS Biopharma Inc. Common Stock position peaked at $482K in Q1 2015.
  • 10 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q2 2015.

Based on Deerfield Management's 13F filing for Q2 2015, filed 14 Aug 2015.